Shilajit (Expanded) for Cognitive Function

Research suggests that shilajit and its primary active compound, fulvic acid, may support cognitive function through several proposed mechanisms, including inhibiting the aggregation of tau protein associated with Alzheimer's disease, reducing acetylcholinesterase activity in memory-related brain regions, and promoting neuronal growth in laboratory models. The available evidence comes predominantly from preclinical studies conducted in cell cultures and animal models, along with a small number of narrative reviews and one limited clinical trial involving a shilajit-plus-B-vitamin formula in mild Alzheimer's patients, meaning the overall body of evidence remains early-stage and largely preliminary. Studies indicate that fulvic acid's proposed role in disrupting tau fibril formation and supporting cholinergic signaling represents a biologically plausible basis for further investigation, and shilajit has also been discussed as a component in multi-ingredient nutraceutical strategies targeting the multiple biological pathways involved in age-related cognitive decline. Notably, one elemental analysis study identified concerning levels of heavy metals, including lead, arsenic, and mercury, in commercially available shilajit products, which represents an important safety consideration that the research literature has not yet adequately addressed alongside efficacy claims.